Product Categories
Country: | China |
---|---|
Tel: | 0531-+86-0531-69954981 |
Mobile: | +8615666777973 |
E-mail: | dwyane.wang@boyuanpharm.com |
QQ: | 327786186 |
Skype: | Chat Now! |
Address: | NO.12 TAIXING EAST STREET, JIBEI ECONOMIC DEVELOPMENT ZONE, JIYANG DISTRICT,JINAN CITY, 251400, SHANDONG,CHINA |
We are one of the well-known Chinese manufacturers of key Active Pharmaceutical Ingredients (APIs) and Intermediates with 20 years of experience and a presence in 20+ countries in the pharma sector. At Boyuan, we are committed to providing high-quality products and services with a team of experienced and qualified experts in R&D, QA, QC, and Manufacturing functions.
Formerly known as “Jinan Boyuan Chemical Co., Ltd” and “Shandong Boyuan Chemical Co., Ltd,” Boyuan was founded in June 2001, and we obtained the Drug Manufacturing License in January 2012. Currently, Boyuan operates two manufacturing plants located in Jiyang and Yucheng, Shandong, China. Covering an area of 30,000㎡, the Jiyang plant consists of 6 workshops with complete facilities and support functions. The Yucheng plant covers an area of 106,668㎡ and includes 12 workshops with complete facilities and public utilities, including a quality inspection center, warehousing, purified water preparation center, power distribution, boiler, sewage disposal, tank farm, and other auxiliary facilities. Both plants are established in line with the GMP standard, adhering to a strict quality management system, and conforming to international standards.
Boyuan is dedicated to producing anti-cancer, anti-tumor, anti-fungal, and other APIs and Intermediates with a team of experienced and qualified employees. We are devoted to technology innovation, extraordinary product quality and pursuing an excellent and responding customer service in a global vision.
|
Product Name | MF | CAS | Details |
---|
Carboplatin | C6H12N2O4Pt | 41575-94-4 | Details |
Cisplatin | Cl2H6N2Pt | 15663-27-1 | Details |
Oxaliplatin | C8H12N2O4Pt | 61825-94-3 | Details |
Capecitabine | C15H22FN3O6 | 154361-50-9 | Details |
Pemetrexed disodium hepthydrate | C20H24N5NaO7 | 357166-29-1 | Details |
Zoledronic acid hydrate | C5H12N2O8P2 | 165800-06-6 | Details |
Lapatinib | C29H26ClFN4O4S | 231277-92-2 | Details |
Lapatinib ditosylate monohydrate | C41H40ClFN4O11S3 | 388082-78-8 | Details |
Lapatinib ditosylate | C36H34ClFN4O7S2 | 388082-77-7 | Details |
Dasatinib monohydrate | C22H28ClN7O3S | 863127-77-9 | Details |
Dasatinib | C22H26ClN7O2S | 302962-49-8 | Details |
4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide | C21H19ClN4O4 | 417716-92-8 | Details |
Lenvatinib mesylate | C22H23ClN4O7S | 857890-39-2 | Details |
Osimertinib | C28H33N7O2 | 1421373-65-0 | Details |
AZD-9291 mesylate | C29H37N7O5S | 1421373-66-1 | Details |
Tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate | C14H22N4O2 | 571188-59-5 | Details |
6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one | C13H13BrClN3O | 1016636-76-2 | Details |
4-[6-[(6-Bromo-8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid 1,1-dimethylethyl ester | C27H34BrN7O3 | 571188-82-4 | Details |
4-[6-[[6-(1-Butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino]pyridin-3-yl]piperazine-1-carboxylic acid tert-butyl ester | C33H45N7O4 | 866084-31-3 | Details |
3-Amino-2,6-piperidinedione hydrochloride | C5H9ClN2O2 | 24666-56-6 | Details |
Methyl 2-bromomethyl-3-nitrobenzoate | C9H8BrNO4 | 98475-07-1 | Details |
3-(4-Nitro-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione | C13H11N3O5 | 827026-45-9 | Details |
Bortezomib | C19H25BN4O4 | 179324-69-7 | Details |
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate | C17H29BF3NO4 | 179324-87-9 | Details |
Dicydoplatin | C12H18N2O8Pt | 287402-09-9 | Details |
Nedaplatin | C2H6N2O3Pt | 95734-82-0 | Details |
Hexachloroplatinum(Ⅳ)Acid Hydrat | Cl6H2Pt | 16941-12-1 | Details |
Potassium hex achloroplatinate(IV) | Cl6KPt- | 16921-30-5 | Details |
Potassium tetrachloroplatinate(Ⅱ) | Cl4KPt- | 10025-99-7 | Details |
Trans-1,2-diaminocyclohexane | C6H14N2 | 1121-22-8 | Details |
(1R,2R)-(-)-1,2- diaminocyclohexane acid | C6H14N2 | 20439-47-8 | Details |
1,2,3-triacetyl-5-deoxy-β-D-Ribose | C11H16O7 | 62211-93-2 | Details |
2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine | C13H16FN3O6 | 161599-46-8 | Details |
5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-diacetate | C19H26FN3O8 | 162204-20-8 | Details |
Tegafur | C8H9FN2O3 | 17902-23-7 | Details |
4-Chloro-6-iodoquinazoline | C8H4ClIN2 | 98556-31-1 | Details |
6-Iodo-4-hydroxyquinazoline | C8H5IN2O | 16064-08-7 | Details |
2-Formylfuran-5-boronic acid | C5H5BO4 | 27329-70-0 | Details |
2-Aminoethylmethylsulfone hydrochloride | C3H10ClNO2S | 104458-24-4 | Details |
3-Chloro-4-(3-fluorobenzyloxy)nitrobenzene | C13H9ClFNO3 | 443882-99-3 | Details |
3-Chloro-4-(3-fluorobenzyloxy)aniline | C13H11ClFNO | 202197-26-0 | Details |
N-[3-Chloro-4-(3-fluorobenzyloxy) phenyl]-6-iodoquinazolin-5-amine | C21H14ClFIN3O | 231278-20-9 | Details |
5-[4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl]-2-furaldehyde | C26H17ClFN3O3 | 231278-84-5 | Details |
Ethyl 2-aminothiazole-5-carboxylate | C6H8N2O2S | 32955-21-8 | Details |
2-(tert-Butoxycarbonylamino)thiazole-5-carboxylic acid | C9H12N2O4S | 302964-02-9 | Details |
2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide | C11H10ClN3OS | 302964-24-5 | Details |
N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-yrimidinyl)amino]-5-thiazolecarboxamide | C16H13Cl2N5OS | 302964-08-5 | Details |
4-Chloro-7-methoxyquinoline-6-carboxamide | C11H9ClN2O2 | 417721-36-9 | Details |
1,4-Dihydro-7-methoxy-4-oxo-6-quinolinecarboxylic acid methyl ester | C12H11NO4 | 205448-65-3 | Details |
4-Chloro-7-methoxyquinoline-6-carboxylic acid methyl ester | C12H10ClNO3 | 205448-66-4 | Details |
4-Amino-3-chlorophenol | C6H6ClNO | 17609-80-2 | Details |
4-Amino-3-chlorophenol hydrochloride | C6H7Cl2NO | 52671-64-4 | Details |
N-(2-Chloro-4-hydroxyphenyl)-N'-cyclopropyl-urea | C10H11ClN2O2 | 796848-79-8 | Details |
N-(4-fluoro-2-Methoxy-5-nitrophenyl)-4-(1-Methylindol-3-yl)pyriMidin-2-aMine | C20H16FN5O3 | 1421372-94-2 | Details |
1,4-BenzenediaMine, N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]-2-nitro- | C25H29N7O3 | 1421372-67-9 | Details |
Mutated EGFR-IN-1 | C25H31N7O | 1421372-66-8 | Details |
4-fluoro-2-Methoxy-5-nitroaniline | C7H7FN2O3 | 1075705-01-9 | Details |
3-(2-chloropyriMidin-4-yl)-1-Methylindole | C13H10ClN3 | 1032452-86-0 | Details |
N. N, N '- trimethylethylenediamine | C5H14N2 | 142-25-6 | Details |
5-Bromo-2-nitropyridine | C5H3BrN2O2 | 39856-50-3 | Details |
1-Boc-4-(6-nitropyridin-3-yl)piperazime | C14H20N4O4 | 571189-16-7 | Details |
5-Bromo-2-chloro-4-(cyclopentylamino)pyrimidine | C9H11BrClN3 | 733039-20-8 | Details |
2-Chloro-8-cyclopentyl-5-methyl-8H-pyrido[2,3-d]pyrimidin-7-one | C13H14ClN3O | 1013916-37-4 | Details |
Lenalidomide hemihydrate | C26H28N6O7 | 847871-99-2 | Details |
N-(2-Pyrazinylcarbonyl)-L-phenylalanine | C14H13N3O3 | 114457-94-2 | Details |
Trans-1,2-diamin ocyclohexane-N,,N’N’-tetraacetic acid | C14H24N2O9 | Details |
Enzalutamide | C21H16F4N4O2S | 915087-33-1 | Details |
4-Bromo-2-fluoro-N-methylbenzamide | C8H7BrFNO | 749927-69-3 | Details |
N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine | C12H15FN2O3 | 1289942-66-0 | Details |
Pemetrexed disodium hemipenta hydrate | C20H24N5NaO7 | 357166-30-4 | Details |
Diethyl L-glutamate hydrochloride | C9H18ClNO4 | 1118-89-4 | Details |
Pemetrexed disodium INT-3;4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic Acid Methyl Ester | C16H16N4O3 | 155405-80-4 | Details |
Pemetrexed disodium INT-4;4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]-Benzoic Acid | C15H14N4O3 | 137281-39-1 | Details |
Pemetrexed disodium INT-5;N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid 1,5-diethyl ester 4-methylbenzenesulfonate | C31H37N5O9S | 165049-28-5 | Details |
Pemetrexed disodium INT-6; Pemetrexed Diacid; | C20H21N5O6 | 137281-23-3 | Details |
Cyclophosphamide monohydrate | C7H17Cl2N2O3P | 6055-19-2 | Details |
Ifosfamide | C7H15Cl2N2O2P | 3778-73-2 | Details |
3-(2-Chloroactyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide | C7H13Cl2N2O3P | 72578-71-3 | Details |
Olaparib | C24H23FN4O3 | 763113-22-0 | Details |
3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid | C10H11O5P | 61260-15-9 | Details |
2-Fluoro-5-[(3-oxo-1(3H)-isobenzofuranylidene)methyl]-benzonitrile | C16H8FNO2 | 763114-25-6 | Details |
1(3H)-Isobenzofuranone, 3-[(3-bromo-4-fluorophenyl)methylene]-, (3Z)- | C15H8BrFO2 | 1423030-14-1 | Details |
2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzoic acid | C16H11FN2O3 | 763114-26-7 | Details |
Lenalidomide | C13H13N3O3 | 191732-72-6 | Details |
4-Isothiocyanato-2-(trifluoromethyl)benzonitrile | C9H3F3N2S | 143782-23-4 | Details |
1(2H)-Phthalazinone, 4-[(3-bromo-4-fluorophenyl)methyl]- | C15H10BrFN2O | 1062292-60-7 | Details |
Piperazine, 1-(cyclopropylcarbonyl)-, Monohydrochloride | C8H15ClN2O | 1021298-67-8 | Details |
2-FLUORO-5-FORMYLBENZONITRILE | C8H4FNO | 218301-22-5 | Details |
N-methyl-1-naphthalenemethylamine | C12H13N | 14489-75-9 | Details |
Terbinafine base | C21H25N | 91161-71-6 | Details |
3,3-Dimethyl-1-Butyne | C6H10 | 917-92-0 | Details |
1-CHLORO-6,6-DIMETHYL-2-HEPTEN-4-YNE | C9H13Cl | 126764-17-8 | Details |
Butenafine hydrochloride | C23H27N.ClH | 101827-46-7 | Details |
Mitiglinide calcium | C38H52CaN2O8 | 207844-01-7 | Details |
Cis-hexahydroisoindoline | C8H15N | 21850-12-4 | Details |
Cis-hexahydroisoindolineHCL | C8H16ClN | 161829-92-1 | Details |
2-Benzylsuccinic acid | C11H12O4 | 36092-42-9 | Details |
S-Benzyl succinic acid | C11H12O4 | 3972-36-9 | Details |
Empagliflozin | C23H27ClO7 | 864070-44-0 | Details |
Terbinafine Hydrochloride | C21H26ClN | 78628-80-5 | Details |
Product Total: Product Page: | ||||
1 2 |